cro.directory
← Compare landing

AXOlabs vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAXOlabsScinai Immunotherapeutics Ltd.
SummaryIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • In Vitro Pharmacology
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Bioinformatics & Data Science
  • Oligonucleotide Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Biologics Development & Manufacturing
  • Recombinant Protein Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Oligonucleotide
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.
  • Immunology
  • Rare Disease
  • Dermatology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Phase I
  • Phase II
  • Phase III
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
Certifications
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production

Find similar companies

AXOlabs alternatives · Scinai Immunotherapeutics Ltd. alternatives

Markdown mirror: /compare/axolabs/scinai-immunotherapeutics.md